Atomac Pediatric Trauma Research Network (EIN 991931932) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2023

Principal Officer

David Notrica

Phone

6025102341

Tax Period

2025-01-01 to 2025-12-31

Atomac Pediatric Trauma Research Network, founded in 2023, is a small nonprofit in the Medical Research sector that reported $292K in total revenue in fiscal year 2025. Revenue surged 21% from the prior year, signaling strong growth momentum. The organization ran a surplus of $174K, a strong 60% operating margin.

Mission

To advance and inspire pediatric trauma research through multicenter collaboration, answering the most pressing clinical questions, and improving outcomes for injured children.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2025)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $290,693

Investment Income $1,356

Other Revenue $0

TOTAL REVENUE $292,049

Expense Breakdown

Grants Paid $100,808

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $107,679

Other Expenses $16,886

TOTAL EXPENSES $117,694

Year-over-Year Comparison

	2025	2024	Change
Revenue	$292,049	$241,767	+0.2%
Expenses	$117,694	$27,669	+3.3%
Net Income	$174,355	$214,098	-0.2%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

N/A

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Role	Reportable Comp	Other Comp	Total
David Notrica MD	President	Director	$0	$0	$0
R Todd Maxson MD	Vice President	Director	$0	$0	$0
Regan F Williams MD	Director	Director	$0	$0	$0
Jeremy Johnson MD	Director	Director	$0	$0	$0
Jessica Naiditch MD	Secretary	Director	$0	$0	$0
Mark Ryan MD	Director	Director	$0	$0	$0
Karla Lawson PhD RN	Treasurer	Director	$0	$0	$0
Katie Russell MD	Director	Director	$0	$0	$0
Barbara Gaines MD	Director	Director	$0	$0	$0
John Petty MD	Director	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$292,049	$117,694	$388,453	$174,355
2024	$241,767	$27,669	$219,852	$214,098

Atomac Pediatric Trauma Research Network